Class III Antiarrhythmic Drugs

No abstract is available for this paper.

• Publication year

  2020

• Venue

  Antiarrhythmic Drugs

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1007/3-540-29832-0_364
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Meta-Analysis Comparing the Relative Risk of Adverse Events for Amiodarone Versus Placebo.

  2019cited by this paper
• Happy 50th anniversary of amiodarone (1969-2019).

  2019cited by this paper
• 2019 ESC Guidelines for the management of patients with supraventricular tachycardiaThe Task Force for the management of patients with supraventricular tachycardia of the European Society of Cardiology (ESC).

  2019cited by this paper
• 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy.

  2018cited by this paper
• Amiodarone-Induced Thyroid Dysfunction: A Clinical Update

  2018cited by this paper
• 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death.

  2018cited by this paper
• Amiodarone-induced pulmonary toxicity

  2017cited by this paper
• Efficacy and safety of dronedarone in the treatment of patients with atrial fibrillation

  2017cited by this paper
• 2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.

  2016cited by this paper
• Randomized comparison of intravenous procainamide vs. intravenous amiodarone for the acute treatment of tolerated wide QRS tachycardia: the PROCAMIO study

  2016cited by this paper
• Amiodarone, Lidocaine, or Placebo in Out-of-Hospital Cardiac Arrest.

  2016cited by this paper
• Amiodarone and dronedarone: An update.

  2016cited by this paper
• 2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.

  2016cited by this paper
• 2015 ESC Guidelines for the Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death.

  2016cited by this paper
• Practical Management Guide for Clinicians Who Treat Patients with Amiodarone.

  2016cited by this paper
• 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS.

  2016cited by this paper
• Amiodarone versus other pharmacological interventions for prevention of sudden cardiac death.

  2015cited by this paper
• [2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy].

  2014cited by this paper
• Recurrence of arrhythmia following short-term oral AMIOdarone after CATheter ablation for atrial fibrillation: a double-blind, randomized, placebo-controlled study (AMIO-CAT trial).

  2014cited by this paper
• Myotonic dystrophy: time for evidence-based therapy.

  2014cited by this paper
• 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society.

  2014cited by this paper
• 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society.

  2014cited by this paper
• Pharmacological conversion of recent-onset atrial fibrillation: A systematic review

  2013cited by this paper
• 54 – Pharmacologic Bases of Antiarrhythmic Therapy

  2013cited by this paper
• Timing and Route of Amiodarone for Prevention of Postoperative Atrial Fibrillation after Cardiac Surgery: A Network Regression Meta‐analysis

  2013cited by this paper
• Dofetilide

  2012cited by this paper
• Dofetilide Reduces the Frequency of Ventricular Arrhythmias and Implantable Cardioverter Defibrillator Therapies

  2012cited by this paper
• Meta‐analysis of amiodarone versus beta‐blocker as a prophylactic therapy against atrial fibrillation following cardiac surgery

  2012cited by this paper
• Amiodarone-associated optic neuropathy: a critical review.

  2012cited by this paper
• The efficacy of sotalol in preventing postoperative atrial fibrillation: a meta-analysis.

  2011cited by this paper
• Ranolazine Reduces Ventricular Tachycardia Burden and ICD Shocks in Patients with Drug‐Refractory ICD Shocks

  2011cited by this paper
• Dronedarone in high-risk permanent atrial fibrillation.

  2011cited by this paper
• Safety and Efficacy of Ibutilide in Cardioversion of Atrial Flutter and Fibrillation

  2011cited by this paper
• Dronedarone.

  2011cited by this paper
• A Short‐Term, Randomized, Double‐Blind, Parallel‐Group Study to Evaluate the Efficacy and Safety of Dronedarone versus Amiodarone in Patients with Persistent Atrial Fibrillation: The DIONYSOS Study

  2010cited by this paper
• Effects of amiodarone therapy on thyroid function

  2010cited by this paper
• Effect of high doses of magnesium on converting ibutilide to a safe and more effective agent.

  2010cited by this paper
• Challenging the superiority of amiodarone for rate control in Wolff-Parkinson-White and atrial fibrillation

  2010cited by this paper
• Amiodarone: review of pulmonary effects and toxicity.

  2010cited by this paper
• Systematic electrocardioversion for atrial fibrillation and role of antiarrhythmic drugs: a substudy of the SAFE-T trial.

  2009cited by this paper
• Dofetilide is safe and effective in preventing atrial fibrillation recurrences in patients accepted for catheter ablation.

  2009cited by this paper
• Effect of dronedarone on cardiovascular events in atrial fibrillation.

  2009cited by this paper
• Atrial tachycardias in young adults and adolescents with congenital heart disease: conversion using single dose oral sotalol.

  2009cited by this paper
• Dofetilide for Atrial Arrhythmias in Congenital Heart Disease: A Multicenter Study

  2009cited by this paper
• Frequency, characteristics, and risk factors for amiodarone neurotoxicity.

  2009cited by this paper
• Comparative efficacy of dronedarone and amiodarone for the maintenance of sinus rhythm in patients with atrial fibrillation.

  2009cited by this paper
• Increased mortality after dronedarone therapy for severe heart failure.

  2008cited by this paper
• Dronedarone for the control of ventricular rate in permanent atrial fibrillation: the Efficacy and safety of dRonedArone for the cOntrol of ventricular rate during atrial fibrillation (ERATO) study.

  2008cited by this paper
• Amiodarone use after acute myocardial infarction complicated by heart failure and/or left ventricular dysfunction may be associated with excess mortality.

  2008cited by this paper
• Conversion efficacy of intravenous ibutilide compared with intravenous amiodarone in patients with recent-onset atrial fibrillation and atrial flutter.

  2007cited by this paper
• Intravenous Magnesium Sulfate Enhances the Ability of Intravenous Ibutilide to Successfully Convert Atrial Fibrillation or Flutter

  2007cited by this paper
• Risk factors and predictors of Torsade de pointes ventricular tachycardia in patients with left ventricular systolic dysfunction receiving Dofetilide.

  2007cited by this paper
• Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter.

  2007cited by this paper
• Amiodarone for atrial fibrillation.

  2007cited by this paper
• ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines

  2006cited by this paper
• Interventions for prevention of post-operative atrial fibrillation and its complications after cardiac surgery: a meta-analysis.

  2006cited by this paper
• Efficacy and Safety of Ibutilide for the Conversion of Monomorphic Atrial Tachycardia

  2006cited by this paper
• Sotalol: the mechanism of its antiarrhythmic-defibrillating effect.

  2006cited by this paper
• Amiodarone is poorly effective for the acute termination of ventricular tachycardia.

  2006cited by this paper
• The novel antiarrhythmic drug dronedarone: comparison with amiodarone.

  2006cited by this paper
• A randomized trial of prophylactic antiarrhythmic agents (amiodarone and sotalol) in patients with atrial fibrillation for whom direct current cardioversion is planned.

  2006cited by this paper
• Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure.

  2005cited by this paper
• Comparison of (cid:1) -Blockers, Amiodarone Plus (cid:1) -Blockers, or Sotalol for Prevention of Shocks From Implantable Cardioverter Defibrillators The OPTIC Study: A Randomized Trial

  2005cited by this paper
• Amiodarone versus sotalol for atrial fibrillation.

  2005cited by this paper
• Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT

  2005cited by this paper
• Effect of dronedarone on renal function in healthy subjects

  2005cited by this paper
• Prevention of atrial fibrillation after cardioversion: results of the PAFAC trial.

  2004cited by this paper
• Ibutilide for cardioversion of atrial flutter: efficacy of a single dose in recent-onset arrhythmias.

  2004cited by this paper
• Long-Term Comparison of the Implantable Cardioverter Defibrillator Versus Amiodarone: Eleven-Year Follow-Up of a Subset of Patients in the Canadian Implantable Defibrillator Study (CIDS)

  2004cited by this paper
• A randomized placebo-controlled trial of pre-treatment and short- or long-term maintenance therapy with amiodarone supporting DC cardioversion for persistent atrial fibrillation.

  2004cited by this paper
• Ibutilide versus amiodarone in atrial fibrillation: A double-blinded, randomized study

  2003cited by this paper
• Amiodarone versus placebo and class Ic drugs for cardioversion of recent-onset atrial fibrillation: a meta-analysis.

  2003cited by this paper
• Effectiveness of amiodarone for conversion of atrial fibrillation to sinus rhythm: a meta-analysis.

  2003cited by this paper
• Effects of Antiarrhythmic Drugs on Fibrillation in the Remodeled Atrium: Insights Into the Mechanism of the Superior Efficacy of Amiodarone

  2003cited by this paper
• Maintenance of sinus rhythm in patients with atrial fibrillation: an AFFIRM substudy of the first antiarrhythmic drug.

  2003cited by this paper
• Efficacy of Metoprolol and Sotalol in the Prevention of Recurrences of Sustained Ventricular Tachyarrhythmias in Patients with an Implantable Cardioverter Defibrillator

  2002cited by this paper
• Amiodarone as compared with lidocaine for shock-resistant ventricular fibrillation.

  2002cited by this paper
• Intravenous lidocaine versus intravenous amiodarone (in a new aqueous formulation) for incessant ventricular tachycardia.

  2002cited by this paper
• Bioavailability of amiodarone tablets administered with and without food in healthy subjects.

  2001cited by this paper
• Efficacy and safety of dofetilide in the prevention of symptomatic episodes of paroxysmal supraventricular tachycardia: a 6-month double-blind comparison with propafenone and placebo.

  2001cited by this paper
• Antiarrhythmic drug use in the implantable defibrillator arm of the Antiarrhythmics Versus Implantable Defibrillators (AVID) Study

  2001cited by this paper
• Efficacy of Dofetilide in the Treatment of Atrial Fibrillation-Flutter in Patients With Reduced Left Ventricular Function: A Danish Investigations of Arrhythmia and Mortality ON Dofetilide (DIAMOND) Substudy

  2001cited by this paper
• A multicentre, double-blind randomized crossover comparative study on the efficacy and safety of dofetilide vs sotalol in patients with inducible sustained ventricular tachycardia and ischaemic heart disease.

  2001cited by this paper
• Effects of amiodarone administration during pregnancy on neonatal thyroid function and subsequent neurodevelopment

  2001cited by this paper
• Electrophysiological Effects of Ibutilide in Patients With Accessory Pathways

  2001cited by this paper
• Efficacy of agents for pharmacologic conversion of atrial fibrillation and subsequent maintenance of sinus rhythm: a meta-analysis of clinical trials.

  2000cited by this paper
• Amiodarone to Prevent Recurrence of Atrial Fibrillation

  2000cited by this paper
• Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg . Canadian Implantable Defibrillator Study.

  2000cited by this paper
• Cardiovascular drugs. Dofetilide.

  2000cited by this paper
• Efficacy and Safety of Oral Dofetilide in Converting to and Maintaining Sinus Rhythm in Patients With Chronic Atrial Fibrillation or Atrial Flutter: The Symptomatic Atrial Fibrillation Investigative Research on Dofetilide (SAFIRE-D) Study

  2000cited by this paper
• Effect of dofetilide in patients with recent myocardial infarction and left-ventricular dysfunction: a randomised trial.

  2000cited by this paper
• Amiodarone and "primary" prevention of sudden death: critical review of a decade of clinical trials.

  1999cited by this paper
• Efficacy and safety of ibutilide fumarate for the conversion of atrial arrhythmias after cardiac surgery.

  1999cited by this paper
• Suppression of sustained ventricular tachyarrhythmias: a comparison of d,l-sotalol with no antiarrhythmic drug treatment.

  1999cited by this paper
• Amiodarone versus propafenone for conversion of chronic atrial fibrillation: results of a randomized, controlled study.

  1999cited by this paper
• Prevention of implantable-defibrillator shocks by treatment with sotalol. d,l-Sotalol Implantable Cardioverter-Defibrillator Study Group.

  1999cited by this paper
• Amiodarone for resuscitation after out-of-hospital cardiac arrest due to ventricular fibrillation.

  1999cited by this paper
• Dofetilide in patients with congestive heart failure and left ventricular dysfunction. Danish Investigations of Arrhythmia and Mortality on Dofetilide Study Group.

  1999cited by this paper
• Evidence-based analysis of amiodarone efficacy and safety.

  1999cited by this paper
• Facilitating transthoracic cardioversion of atrial fibrillation with ibutilide pretreatment.

  1999cited by this paper

• No citing papers are available for this paper.